Goldman Sachs’s Atossa Therapeutics ATOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-22,330
Closed -$278K 6326
2025
Q2
$278K Buy
22,330
+9,802
+78% +$117K ﹤0.01% 5483
2025
Q1
$126K Sell
12,528
-10,463
-46% -$127K ﹤0.01% 5737
2024
Q4
$326K Buy
22,991
+6,382
+38% +$125K ﹤0.01% 5465
2024
Q3
$379K Buy
16,609
+9,765
+143% +$197K ﹤0.01% 5201
2024
Q2
$122K Sell
6,844
-35,060
-84% -$776K ﹤0.01% 5380
2024
Q1
$1.13M Buy
+41,904
New +$673K ﹤0.01% 4262
2022
Q3
Sell
-4,285
Closed -$70K 6251
2022
Q2
$70K Sell
4,285
-2,536
-37% -$40K ﹤0.01% 5955
2022
Q1
$128K Sell
6,821
-10,503
-61% -$213K ﹤0.01% 6025
2021
Q4
$416K Buy
17,324
+3,486
+25% +$128K ﹤0.01% 5485
2021
Q3
$676K Buy
13,838
+10,504
+315% +$611K ﹤0.01% 5014
2021
Q2
$316K Sell
3,334
-917
-22% -$48.5K ﹤0.01% 5488
2021
Q1
$135K Buy
+4,251
New +$155K ﹤0.01% 5763
2020
Q4
Sell
-1,420
Closed -$52K 5476
2020
Q3
$52K Buy
+1,420
New +$68.2K ﹤0.01% 5185
2016
Q3
Sell
-15
Closed -$12K 7005
2016
Q2
$12K Buy
+15
New +$12.2K ﹤0.01% 6825
2016
Q1
Sell
-13
Closed -$11K 7073
2015
Q4
$11K Buy
13
+1
+8% +$1.54K ﹤0.01% 6955
2015
Q3
$24K Buy
+12
New +$30.8K ﹤0.01% 6986
2015
Q1
Sell
-10
Closed -$38K 7064
2014
Q4
$38K Sell
10
-14
-58% -$39.5K ﹤0.01% 6877
2014
Q3
$86K Buy
24
+14
+140% +$68.9K ﹤0.01% 6640
2014
Q2
$47K Sell
10
-5
-33% -$19.4K ﹤0.01% 6772
2014
Q1
$68K Buy
15
+2
+15% +$11.8K ﹤0.01% 6500
2013
Q4
$82K Hold
13
﹤0.01% 6334
2013
Q3
$191K Buy
+13
New +$170K ﹤0.01% 5898

Other funds holding ATOS